SCHEMBL30738868

SCHEMBL30738868

CCOC(=O)[C@H]1CCN(C(=O)OC(C)(C)C)C[C@H]1NC(=O)OC(C)(C)C

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.50
ALDH1A1 P00352 2/20 0.50
KMT2A Q03164 2/20 0.50
TSHR P16473 1/20 0.50
HSD11B1 P28845 6/20 0.42
CYP2C9 P11712 1/20 0.42
EPHX1 P07099 1/20 0.41
MAPT P10636 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PDE4B Q07343 1/20 0.39
PTPN2 P17706 1/20 0.39
PTPN1 P18031 1/20 0.39
PTPN6 P29350 1/20 0.39
USP30 Q70CQ3 1/20 0.39
CTSK P43235 2/20 0.38
GAA P10253 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3980905 0.86 ALDH1A1 (0.42) MEN1ALDH1A1KMT2ATSHREPHX1
SCHEMBL30738914 0.85 HSD11B1 (0.47) HSD11B1CYP2C9EPHX1PDE4BPTPN2
SCHEMBL31340370 0.85 PDE4B (0.52) MEN1ALDH1A1KMT2ATSHRHSD11B1
SCHEMBL6347796 0.85 CPB1 (0.49) MEN1KMT2AHSD11B1MAPTNPSR1
SCHEMBL17756103 0.83 ALDH1A1 (0.48) MEN1ALDH1A1KMT2ATSHREPHX1
SCHEMBL13747445 0.83 MEN1 (0.46) MEN1ALDH1A1KMT2ATSHRHSD11B1
SCHEMBL28637510 0.83 KMT2A (0.39) MEN1ALDH1A1KMT2ATSHREPHX1
SCHEMBL16765557 0.83 KMT2A (0.39) MEN1ALDH1A1KMT2ATSHREPHX1
SCHEMBL16765558 0.83 KMT2A (0.39) MEN1ALDH1A1KMT2ATSHREPHX1
SCHEMBL6355806 0.83 ALDH1A1 (0.45) MEN1ALDH1A1KMT2ATSHREPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062420-A1 NOVEL DPP1 INHIBITORS AND USES THEREOF INSMED INC (US) 2026-03-05 US disclosed
EP-4561565-A2 NOVEL DPP1 INHIBITORS AND USES THEREOF Insmed Incorporated (US) 2025-06-04 EP disclosed
WO-2024026433-A2 NOVEL DPP1 INHIBITORS AND USES THEREOF INSMED INCORPORATED (US) 2024-02-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062420-A1 NOVEL DPP1 INHIBITORS AND USES THEREOF DPP4, DPP3, DPP7 MEN1 3390/4885ALDH1A1 795/4885KMT2A 2665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.